News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
NCI signed a MOU with Ministry of Food and Drug of Republic of Korea
NCI Center for Global Health/LinkedIn
Nov 21, 2024, 13:46

NCI signed a MOU with Ministry of Food and Drug of Republic of Korea

NCI Center for Global Health shared a post on LinkedIn:

“Yesterday, the National Cancer Institute (NCI) was honored to welcome colleagues from the National Institute of Food and Drug Safety Evaluation (NIFDS) of the Republic of Korea Ministry of Food and Drug Safety to sign a memorandum of understanding (MOU).

NCI Director, Dr. Kimryn Rathmell and NIFDS Director General, Dr. Seogyoun Kang signed this MOU underscoring our joint commitment to advancing the prevention, diagnosis, and treatment of cancer worldwide.

Click here to read more.”

NCI signed a MOU with Ministry of Food and Drug of Republic of Korea

cancer Kimryn Rathmell National Cancer Institute National Institute of Food and Drug Safety Evaluation NCI NCI Center for Global Health NIFDS OncoDaily Oncology Republic of Korea Seogyoun Kan
Special Coverage
Science
Jan 6, 2025, 12:40
Chaitanya Bandlamudi: Detailed clinico-genomic landscape of pancreatic adenocarcinomas
Science
Jan 6, 2025, 12:37
Sharlene Gill: Adjuvant immunotherapy in patients with resected ESO/GEJ cancer
Career
Jan 6, 2025, 12:35
Kicking of exciting new season of Inside Cancer Careers with LeeAnn Bailey - Train at NCI
Blog
Jan 6, 2025, 12:33
Revolutionizing Cancer Care - Canary Oncoceutics
Blog
Jan 6, 2025, 12:31
Banu Arun: Pioneering New Horizons in BRCA-Positive Breast Cancer Treatment
Blog
Jan 6, 2025, 12:31
Raising Radon Awareness - ALCSI
Insight
Jan 6, 2025, 12:28
We are proud to be the first non-profit 100% dedicated to Myelodysplastic Syndromes - MDS Foundation
Insight
Jan 6, 2025, 12:15
Erman Akkus: Adjuvant pembrolizumab after surgery in high risk muscle invasive bladder cancer
Blog
Jan 6, 2025, 11:56
Julie Gerberding: Extermely fortunate to benefit from Ellen Sigal’s passionate leadership as a member of FNIH Board
Blog
Jan 6, 2025, 11:54
Pashtoon Kasi: Have to be mindful of rare side effects of Immunotherapy
Blog
Jan 6, 2025, 11:39
Sami (Papacek) Mansfield: The next cohort of the My Lifestyle Shift program
Blog
Jan 6, 2025, 11:35
Biagio Ricciuti: TROPICS-03 trial - Sacituzumab Govitecan in 2L extensive stage SCLC